Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination

► First time therapeutic vaccine IC41 in treatment naive CHC patients. ► Significant HCV viral load decline more pronounced in high viral load patients. ► Enhanced effect of IC41 with toll like receptor 7 agonist.